Veracyte announces 10 Afirma thyroid test studies for ATA 2026 meeting
VCYT•Veracyte announced 10 Afirma thyroid test abstracts for the American Thyroid Association meeting, scheduled for Nov. 4-7, 2026, in Philadelphia. The program includes two oral presentations and eight posters.
1. Meeting presentations
The program includes five studies conducted independently of Veracyte. Findings link gene expression to tumor invasion, while other studies assess preoperative diagnosis, recurrence risk and potential treatment targets.
